![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CM Life Sciences III Inc | NASDAQ:CMLT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.69 | 8.49 | 8.88 | 0 | 01:00:00 |
|
Delaware
(State or other jurisdiction of
incorporation or organization) |
| |
84-1691173
(I.R.S. Employer
Identification Number) |
|
|
Large accelerated filer
☒
|
| |
Accelerated filer
☐
|
| | ||
|
Non-accelerated filer
☐
|
| |
Smaller reporting company
☐
|
| | ||
| | | |
Emerging growth company
☐
|
| | | |
| | | | | ii | | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 4 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 7 | | | |
| | | | | 14 | | | |
| | | | | 20 | | | |
| | | | | 21 | | | |
| | | | | 24 | | | |
| | | | | 27 | | | |
| | | | | 27 | | | |
| | | | | 27 | | | |
| | | | | 28 | | |
|
SEC registration fee
|
| | | $ | 33,060 | | |
|
FINRA filing fee
|
| | | $ | 45,500 | | |
|
Legal fees and expenses
|
| | | | * | | |
|
Accounting fees and expenses
|
| | | | * | | |
|
Miscellaneous
|
| | | | * | | |
|
Total
|
| | | | * | | |
|
Exhibit
No. |
| |
Description
|
|
| 1.1* | | | Form of Underwriting Agreement | |
| 3.1 | | | | |
| 3.2 | | | | |
| 4.1 | | | | |
| 4.2* | | | Specimen Certificate for Preferred Stock | |
| 4.3* | | | Form of Certificate of Designations | |
| 4.4** | | | | |
| 4.5** | | | | |
| 4.6* | | | Form of Warrant Agreement (including Form of Warrant Certificate) | |
|
Exhibit
No. |
| |
Description
|
|
| 4.7* | | | Form of Unit Agreement (including Form of Unit Certificate) | |
| 5.1** | | | | |
| 23.1** | | | | |
| 23.2** | | | | |
| 24.1** | | | | |
| 25.1*** | | | Form T-1 Statement of Eligibility of Trustee for Senior Indenture under the Trust Indenture Act of 1939, as amended | |
| 25.2*** | | | Form T-1 Statement of Eligibility of Trustee for Subordinated Indenture under the Trust Indenture Act of 1939, as amended | |
| 107** | | | |
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ Melanie Nallicheri
Melanie Nallicheri
|
| |
President, Chief Executive Officer, and Director
(Principal Executive Officer) |
| |
February 23, 2023
|
|
|
/s/ Jami Rubin
Jami Rubin
|
| |
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer) |
| |
February 23, 2023
|
|
|
/s/ Alexis Borisy
Alexis Borisy
|
| |
Chairman of the Board
|
| |
February 23, 2023
|
|
|
/s/ Amy Abernethy
Amy Abernethy
|
| |
Director
|
| |
February 23, 2023
|
|
|
/s/ Paul Berns
Paul Berns
|
| |
Director
|
| |
February 23, 2023
|
|
|
/s/ Jorge Conde
Jorge Conde
|
| |
Director
|
| |
February 23, 2023
|
|
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ Kathryn Giusti
Kathryn Giusti
|
| |
Director
|
| |
February 23, 2023
|
|
|
/s/ Sandra Horning
Sandra Horning
|
| |
Director
|
| |
February 23, 2023
|
|
|
/s/ Clive Meanwell
Clive Meanwell
|
| |
Director
|
| |
February 23, 2023
|
|
|
/s/ Samuel Merksamer
Samuel Merksamer
|
| |
Director
|
| |
February 23, 2023
|
|
|
/s/ Krishna Yeshwant
Krishna Yeshwant
|
| |
Director
|
| |
February 23, 2023
|
|
1 Year CM Life Sciences III Chart |
1 Month CM Life Sciences III Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions